Back to Search
Start Over
Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer.
- Source :
-
International journal of biological sciences [Int J Biol Sci] 2017 Mar 12; Vol. 13 (4), pp. 471-479. Date of Electronic Publication: 2017 Mar 12 (Print Publication: 2017). - Publication Year :
- 2017
-
Abstract
- Triple-negative breast cancer (TNBC) is a subtype of breast cancer with a poor prognosis, accounting for approximately 12-24% of breast cancer cases. Accumulating evidence has indicated that there is no effective targeted therapy available for TNBC. Dipalmitoylphosphatidic acid (DPPA) is a bioactive phospholipid. However, the function of DPPA in the growth of TNBC has not yet been studied. In this study, we employed TNBC cells and a subcutaneous tumor model to elucidate the possible effect of DPPA on tumor growth in TNBC. We showed that DPPA significantly inhibited tumor growth in the mouse subcutaneous tumor model and suppressed cell proliferation and angiogenesis in TNBC tumor tissues. This inhibition was mediated partly by suppressing the expression of cyclin B1 (CCNB1), which directly promoted the accumulation of cells in the G2 phase and arrested cell cycle progression in human TNBC. In addition, the inhibition of tumor growth by DPPA may also be mediated by the suppression of tumor angiogenesis in TNBC. This work provides initial evidence that DPPA might be vital as an anti-tumor drug to treat TNBC.<br />Competing Interests: Competing Interests: The authors have declared that no competing interest exists.
- Subjects :
- Animals
Antineoplastic Agents pharmacology
Antineoplastic Agents therapeutic use
Cell Cycle drug effects
Cell Cycle genetics
Cell Line
Cell Line, Tumor
Female
Flow Cytometry
G2 Phase drug effects
G2 Phase genetics
Humans
Immunoblotting
Male
Mice
Mice, Inbred BALB C
Mice, Nude
Triple Negative Breast Neoplasms genetics
Triple Negative Breast Neoplasms metabolism
Xenograft Model Antitumor Assays
Apoptosis drug effects
Cell Proliferation drug effects
Phosphatidic Acids pharmacology
Phosphatidic Acids therapeutic use
Triple Negative Breast Neoplasms drug therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1449-2288
- Volume :
- 13
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- International journal of biological sciences
- Publication Type :
- Academic Journal
- Accession number :
- 28529455
- Full Text :
- https://doi.org/10.7150/ijbs.16290